If you need more lookups,
subscriptions start at $34 USD/month.
Chris Britten Location
Cambridge, GB
Chris Britten Work
2026 -now Chief Business Officer @
2019 -now Non Executive Chair @
2012 -now Managing Director @ Vantage Life Science Consulting
2023 -2025 Senior Vice President, Global Business Development @
2022 -2023 Senior Vice President, M and A @
2019 -2022 Global Head, M and A @
2017 -2019 Global Head, M and A @
2015 -2017 Managing Director @
2014 -2016 Non Executive Director @ Phico Therapeutics Ltd.
2013 -2015 Head, Business Development @ Sanofi Pasteur MSD
2011 -2012 Business and Commercial Development Director @ Astellas Pharma Europe
2008 -2011 Director, Life Sciences, Corporate Finance Advisory @
2004 -2008 Director, Worldwide Business Development @
2002 -2004 Director, GSK Ventures @
1992 -2002 Project Leader and Scientist @
Chris Britten Education
London Business School
MBA (Finance, Entrepreneurship, Strategy)
University of York
PhD (Biochemistry)
University of York
BSc (Hons) (Biology)
Chris Britten Skills
Financial Modeling
Acquisitions
Pharmaceuticals
Biotechnology
New Business Development
R&D
Lifesciences
Mergers
Business Development
Drug Discovery
Drug Development
Due Diligence
Medical Devices
Mergers & Acquisitions
Pharmaceutical Industry
Licensing
Corporate Finance
Clinical Development
Corporate Development
Strategy
Intellectual Property
Life Sciences
Mergers and Acquisitions
Chris Britten Summary
Chris Britten, based in Cambridge, GB, is currently a Chief Business Officer at Diode Bio. Chris Britten brings experience from previous roles at Thalia Therapeutics Plc, Vantage Life Science Consulting, Grünenthal Group and ADVANZ PHARMA. Chris Britten holds a MBA in Finance, Entrepreneurship, Strategy @ London Business School. With a robust skill set that includes Financial Modeling, Acquisitions, Pharmaceuticals, Biotechnology, New Business Development and more. Chris Britten has 3 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Chris Britten?
Find contact details for 700 million professionals.